← All Merck & Co, INC filings

Merck & Co, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
MRK
Merck & Co, INC
DEF: Merck's 2026 Shareholder Meeting: Director Elections & Compensation
Merck & Co., Inc. has issued its 2026 Proxy Statement detailing the agenda for its Annual Meeting of Shareholders, including the election of directors, advisory vote on executive compensation, and ratification of its auditor.
NYSE
MRK
Merck & Co, INC
DEFA14A: Merck & Co. Sets Date for 2025 Annual Shareholder Meeting, Outlines Proposals
Merck & Co. announces its 2025 Annual Meeting of Shareholders to be held virtually on May 27, 2025, outlining key proposals for voting.
NYSE
MRK
Merck & Co, INC
DEF: Merck & Co. Invites Shareholders to 2025 Annual Meeting, Highlights Strategic Progress and Pipeline Expansion
Merck & Co. announces its 2025 Annual Meeting of Shareholders, highlighting advancements in medicines and vaccines, strategic priorities, and pipeline expansion.
NYSE
MRK
Merck & Co, INC
DEFA14A: Merck & Co. Sets Date for 2024 Annual Meeting, Outlines Proposals for Shareholder Vote
Merck & Co. has scheduled its 2024 Annual Meeting for May 28, 2024, and is seeking shareholder votes on director elections, executive compensation, auditor ratification, and various shareholder proposals.
NYSE
MRK
Merck & Co, INC
DEF 14A: Merck & Co. Outlines Strategy and Governance in Proxy Statement
Merck & Co.'s proxy statement details the company's strategy, governance, and executive compensation for the upcoming annual meeting.